98-5673. Manufacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 63, Number 43 (Thursday, March 5, 1998)]
    [Notices]
    [Page 10945]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-5673]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Application
    
        Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
    Regulations (CFR), this is notice that on December 30, 1997, 
    Mallinckrodt Chemical, Inc., Mallinckrodt & Second Streets, St. Louis, 
    Missouri 63147, made application by renewal to the Drug Enforcement 
    Administration (DEA) for registration as a bulk manufacturer of the 
    basic classes of controlled substances listed below:
    
    ------------------------------------------------------------------------
                        Drug                               Schedule         
    ------------------------------------------------------------------------
    Tetrahydrocannabinols (7370)...............  I                          
    Methylphenidate (1724).....................  II                         
    Cocaine (9041).............................  II                         
    Codeine (9050).............................  II                         
    Diprenorphine (9058).......................  II                         
    Etorphine Hydrochloride (9059).............  II                         
    Dihydrocodeine (9120)......................  II                         
    Oxycodone (9143)...........................  II                         
    Hydromorphone (9150).......................  II                         
    Diphenoxylate (9170).......................  II                         
    Hydrocodone (9193).........................  II                         
    Levorphanol (9220).........................  II                         
    Meperidine (9230)..........................  II                         
    Methadone (9250)...........................  II                         
    Methadone-intermediate (9254)..............  II                         
    Dextropropoxyphene, bulk (non-dosage forms)  II                         
     (9273).                                                                
    Morphine (9300)............................  II                         
    Thebaine (9333)............................  II                         
    Opium extracts (9610)......................  II                         
    Opium fluid extract (9620).................  II                         
    Opium tincture (9630)......................  II                         
    Opium powdered (9639)......................  II                         
    opium granulated (9640)....................  II                         
    Levo-alphacetylmethadol (9648).............  II                         
    Oxymorphone (9652).........................  II                         
    Noroxymorphone (9668)......................  II                         
    Alfentanil (9737)..........................  II                         
    Sufentanil (9740)..........................  II                         
    Fentanyl (9801)............................  II                         
    ------------------------------------------------------------------------
    
        The firm plans to manufacture the controlled substances for 
    distribution bulk products to its customers.
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the proposed registration.
        Any such comments or objections may be addressed, in quintuplicate, 
    to the Deputy Assistant Administrator, Office of Diversion Control, 
    Drug Enforcement Administration, United States Department of Justice, 
    Washington, D.C. 20537, Attention: DEA Federal Register Representative 
    (CCR), and must be filed no later than May 4, 1998.
    
        Dated: February 13, 1998.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 98-5673 Filed 3-4-98; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
03/05/1998
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
98-5673
Pages:
10945-10945 (1 pages)
PDF File:
98-5673.pdf